articleBritish Journal of DermatologyMar 5, 2010Closed access

A first prospective randomized controlled trial to decrease bacterial load using cold atmospheric argon plasma on chronic wounds in patients

München Klinik Schwabing · Max Planck Society · +2 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

Background

Bacterial colonization of chronic wounds slows healing. Cold atmospheric plasma has been shown in vitro to kill a wide range of pathogenic bacteria. Objectives To examine the safety and efficiency of cold atmospheric argon plasma to decrease bacterial load as a new medical treatment for chronic wounds. PATIENTS AND METHODS: Thirty-eight chronic infected wounds in 36 patients were treated in a prospective randomized controlled phase II study with 5 min daily cold atmospheric argon plasma in addition to standard wound care. The patient acted as his or her own control. Bacterial species were detected by standard bacterial swabs and semiquantitative changes by nitrocellulose filters. Plasma setting and safety had been determined in a preceding phase I study.

Results

Analysis of 291 treatments in 38 wounds found a highly significant (34%, P

Citation impact

686
total citations
FWCI
28.41
Percentile
100%
References
15
Citations per year

Authors

15

Topics & keywords

Keywords
  • Medicine
  • Randomized controlled trial
  • Atmospheric-pressure plasma
  • Bacteria
  • Prospective cohort study
  • Argon
  • Surgery
  • Wound healing
No related works found for this paper.